1. , , , et al. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod 2007;22:1973–81.
2. , , , et al. European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 2008;23:756–71.
3. , , , et al. ESHRE’s European IVF Monitoring (EIM). On the benefit of assisted reproduction techniques, a comparison of the USA and Europe. Hum Reprod 2006;21:21.
4. , , . Paracrine dialogue in implantation. Mol Cell Endocrinol 2002;186:175–81.
5. , , . Wide genomic analysis of human endometrial receptivity: new times, new opportunities. Hum Reprod Update 2007;13:77–86.
6. , , , . Applications of proteomics methodologies to human pregnancy research: a growing gestation approaching delivery? Proteomics 2004;4:1909–17.
7. , , , et al. Proteomic analysis of the proliferative and secretory phases of the human endometrium: Protein identification and differential protein expression. Proteomics 2005;5:270–81.
8. , , , et al. Proteomic analysis of the human receptive versus non-receptive endometrium using differential in-gel electrophoresis and MALDI-MS unveils Stathmin 1 and Annexin A2 as differentially regulated. Hum Reprod 2009;24:2607–17.
9. , . Protein ectodomain shedding. Chem Rev 2002;102:4627–38.
10. . Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol 2000;12:606–12.
11. , , , et al. Endometrial secretion aspiration prior to embryo transfer does not reduce implantation rates. Reprod Biomed Online 2003;7:105–9.
12. , , . MUC1 and endometrial receptivity. Mol Hum Reprod 1998;4:1089–98.
13. , , , et al. Use of integrins to date the endometrium. Fertil Steril 2000;73:779–87.
14. , , , et al. The role of the endometrium and embryo in human implantation. Hum Reprod Update 2007;13:365–77.
15. , . Protein patterns of human uterine flushings collected at various stages of the menstrual cycle. J Reprod Fertil 1978;53:343–8.
16. , . Molecular and cellular aspects of endometrial receptivity. Hum Reprod Update 1998;4:448–58.
17. , , . The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 1997;12:569–74.
18. , , , et al. The correlation of placental protein 14 concentrations in uterine flushings and endometrial morphology in the peri-implantation period. Hum Reprod 1993;8:1923–7.
19. , , , et al. Progestins, progesterone receptor modulators, and progesterone antagonist change VEGF release of endometrial cells in culture. Steroids 2000;65:763–71.
20. , , , et al. Hormonal regulation of serum and endometrial IL-1α, IL-1β and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31:165–84.
21. , , , et al. Reduced expression of interleukin-11 and interleukin-6 in the peri-implantation endometrium of excessive ovarian responders during in-vitro fertilization treatment. J Clin Endocrinol Metab 2006;91:3181–8.
22. , , , et al. Concentrations of steroid hormones, and of prolactin, in washings of the human uterus during the menstrual cycle. J Reprod Fertil 1986;78:21–5.
23. , , , et al. Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum Reprod Update 1998;4:532–8.
24. , , , et al. Contribution to the physiology and pathology of endometrial receptivity: the determination of proteins patterns in human uterine secretions. Hum Reprod 1989;4:115–20.
25. , , , et al. Endometrial secretion aspiration prior to embryo transfer does not reduce implantation rates. Reprod Biomed Online 2003;7:105–9.
26. , , . The techniques and complications of out-patient uterine washing in the assessment of endometrial function. Hum Reprod 1993;8:343–6.
27. , , , et al. Assessment of leukemia inhibitary factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization. Fertil Steril 2003;79:900–4.
28. , , , et al. Impact of ovarian stimulation on mid-luteal endometrial tissue and secretion markers of receptivity. Reprod Biomed Online 2008;4:553–63.
29. , , , et al. Comprehensive proteomic analysis of human endometrial fluid aspirate. J Proteome Res 2009;8:4622–32.
30. , , , et al. Analysis of embryonic mouse development: construction of a high-resolution, two-dimensional gel protein database. Appl Theor Electrophor 1992;2:163–70.
31. , , , et al. Protein databases for compacted eight-cell and blastocyst-stage mouse embryos. Mol Reprod Develop 1994;37:34–47.
32. , , , et al. Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos. Reproduction 2004;128:503–16.
33. , , , et al. Increases in phosphorylation of SAPK/JNK and p38MAPK correlate negatively with mouse embryo development after culture in different media. Fertil Steril 2005;83:1144–54.
34. , , , et al. Microproteomics: analysis of protein diversity in small samples. Mass Spectrom Rev 2008;27:316–30.
35. , , , et al. Protein profiling of B-cell lymphomas using tissue biopsies: a potential tool for small samples in pathology. Cell Oncol 2008;30:27–38.
36. , , . Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertil Steril 2006;85:101–7.
37. , , . Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril 2006;86:678–85.
38. , , , et al. A proteomic analysis of mammalian preimplantation embryonic development. Reproduction 2005;130:899–905.
39. , , , et al. Comparative protein-profile analysis of implanted versus non-implanted human blastocysts. Hum Reprod 2008;23:1993–2000.
40. , , , et al. Embryologic outcome and secretome profile of implanted blastocysts obtained after coculture in human endometrial epithelial cells versus the sequential system. Fertil Steril 2010;93:774–82.
41. , , , et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248:220–3.
42. , , , et al. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci U S A 1996;93:161–5.
43. , , , et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005;20:138–46.
44. , , , et al. Soluble human leukocyte antigen G expression in phase I culture media at 46 h after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril 2005;83:1410–13.
45. , , . Soluble HLA-G release by the human embryo: an interesting artefact? Reprod Biomed Online 2006;13:763–4.
46. , , , et al. Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods. J Reprod Immunol 2007;75:11–22.
47. , , , et al. sHLA-G production by human IVF embryos: can it be measured reliably? J Reprod Immunol 2007;75:128–32.
48. , , , et al. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod 2008;23:2596–608.
49. , , , , . Relationship between the human blastocyst secretome and chromosomal constitution. Fertil Steril 2008;90:S80.
50. , , , et al. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic 2005;3:322–31.